Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | TNIK | Q9UKE5 | 4/20 | 0.45 |
| ▸ | IDO1 | P14902 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | KMO | O15229 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31379254 | 0.83 | TNIK (0.40) | MIFNPC1TNIKKMO | |
| SCHEMBL31674301 | 0.83 | TNIK (0.40) | MIFNPC1TNIKKMO | |
| SCHEMBL34475640 | 0.81 | POLB (0.52) | MIFNPC1TNIKALDH1A1KMT2A | |
| SCHEMBL15822463 | 0.72 | MIF (0.42) | MIFNPC1IDO1ALDH1A1 | |
| SCHEMBL16421402 | 0.72 | KMO (0.60) | MIFIDO1KMOKMT2ATP53 | |
| SCHEMBL5344625 | 0.72 | IDO1 (0.58) | MIFIDO1ALDH1A1KMT2A | |
| SCHEMBL16419127 | 0.71 | KMO (0.53) | MIFIDO1ALDH1A1KMOKMT2A | |
| SCHEMBL32683889 | 0.71 | PTGS2 (0.47) | MIFNPC1TNIKIDO1 | |
| SCHEMBL220738 | 0.71 | APP (0.54) | NPC1 | |
| SCHEMBL14931625 | 0.70 | ALDH1A1 (0.47) | NPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069602-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | ACONCAGUA BIO INC (US) | 2026-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069602-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | SCTR, SSTR1, NPY1R | MIF 4719/4885NPC1 190/4885TNIK 4666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.